Preclinical studies show that the drug that is not deposited in bone is rapidly excreted in the urine. No evidence of saturation of bone uptake was found after chronic dosing with cumulative intravenous doses up to 35 mg/kg in animals. Although no clinical information is available, it is likely that, as in animals, elimination of alendronic acid via the kidney will be reduced in patients with impaired renal function. Therefore, somewhat greater accumulation of alendronic acid in bone might be expected in patients with impaired renal function (see section ).
FEMARA is only approved for use in postmenopausal women. You should not take FEMARA if you are premenopausal. Your doctor should discuss the need for adequate birth control if you have the potential to become pregnant (for example, if you are not sure of your postmenopausal status or recently became postmenopausal, or if you are perimenopausal). You should not take FEMARA if you are pregnant, as it may cause harm to an unborn child. You should also discuss with your doctor what to do if you are nursing a child. You and your doctor should decide whether to discontinue nursing or to discontinue the drug.
While 50mg-80mg is the average range, Anavar dosages can safely reach the 100mg per day range. However, there are two important things we must consider. The Oxandrolone hormone is by no means cheap; 10mg tabs can cost anywhere from $2-$5 a piece depending on the source and brand. Further, regarding the 100mg mark, Anavar dosages above this mark will not make a massive difference. The Oxandrolone hormone appears to have a fast falloff point past the 100mg mark. Granted, past 100mg you might see a little more progress, but nothing of any true substance and by no means in any way that has that justified what you’ll be paying for it.